1. Home
  2. Health Care
  3. Piedmont, SC
  4. The Blood Connection

The Blood Connection

The Blood Connection is ranked among health care organizations in Piedmont, SC, with an America's Best Score of 74 out of 100, based on its 2025 Form 990.

  • Piedmont, SC
  • Tax-exempt since 1978
  • EIN: 57-0660489
thebloodconnection.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
74OF 100 Ranked in Piedmont Health Care How this score is calculated

Organization summary

The Blood Connection is a 501(c)(3) organization, classified under Health Care (NTEE E610). Contributions are tax-deductible.

1099 Bracken Rd, Piedmont, SC 29673-9644

In fiscal year 2025 it reported $149,672,688 in revenue and $141,355,040 in expenses, with contributions making up 0.0% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Healthcare partners supported by adequate, safe, cost-effective blood supplies and services.

Largest programs · fiscal year 2025

  • Blood donor program: Allogeneic whole blood donor program: Affords free opportunity for patrons to participate in community service in the form of voluntary whole blood donations. For donors - early detection & treatment opportunity for high blood pressure, anemia, abnormal pulse rate and other illnesses found during blood donor screening. Autologous blood program: Affords free opportunity for pat… Read more

    Blood donor program: Allogeneic whole blood donor program: Affords free opportunity for patrons to participate in community service in the form of voluntary whole blood donations. For donors - early detection & treatment opportunity for high blood pressure, anemia, abnormal pulse rate and other illnesses found during blood donor screening. Autologous blood program: Affords free opportunity for patients to provide their own blood in advance of medical treatment. Reduction in demand on community blood supply, reduced risk of transfusion transmitted disease. Directed blood donor program: Affords opportunity for patients to designate donors of the blood for the patients transfusions. Automated collection apheresis (platelet, plasma & rbc) donor program: Affords free opportunity for patrons to participate in community service in the form of voluntary, automated donations. Therapeutic service program: Provides free therapeutic phlebotomy for patients with blood disorders such a polycythemia and hemochromatosis. Cellular program: Hematopoietic progenitor cell processing services: Provides cellular therapy services including processing, cryopreservation, storage, infusion preparations for immunotherapy, and transplant for both autologous and matched related transplants for multiple myeloma, NHL and hodgkinis lymphoma. Provides transplant product preparation and shipment preparation to an outside facility upon request. The cryogenic storage services are provided free of charge for the first year. Goals: Process 100% of requests for processing and infusions of hematopoietic progenitor cells and donor lymphocytes, offer services 24/7, provide same day turnaround for cd34+ flow cytometry analysis, and produce a product proven to be capable of engraftment. Cellular therapy collection services: Provides cellular collection services for two healthcare providers. One, a biotechnology company (dendreon) applies its expertise in antigen identification, engineering and cell processing to produce an active cellular immunotherapy product called provenge (sipuleucel-t). Provenge is indicated for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. The Blood Connection collects mononuclear cells from prostate cancer patients deemed suitable by their physician and scheduled by dendreon. Post collection, the collected product is shipped to dendreon for further testing and processing; the final product is later transfused back to the patient at their transfusion center. The other provider is a cancer treatment institute affiliated with a local hospital system. The Blood Connection collects circulating bone marrow cells from patients in the remission phase of cellular cancers such as leukemia, lymphoma, and myeloma. Those collections, rich in hematopoietic progenitor cells, are then processed as described above.

    $95,358,967 spent · 71.6% of program spending
  • Additional program expenses include interest expenses and program related administrative expenses. $564,467 spent · 0.4% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 94¢ went to programs, 6¢ to management and 0¢ to fundraising.

  • Programs $133,120,503
  • Management $8,234,537
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score74 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves6.2 mo; 0.3 mo in cash4.3 / 25
Financial balance (median margin)+4.6%19.3 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+14.8% / yr14.9 / 15
Track record48 years10 / 10
Debt load31.9% of assets5.6 / 10
Total74.1 → 74
Spending on programs
Not scored; America's Best needs 65%+
94%Meets

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$149,672,688Fiscal year 20252022: $98,048,52320222023: $118,297,63020232024: $144,446,57320242025: $149,672,6882025
Expenses$141,355,040Fiscal year 20252022: $93,545,31220222023: $114,124,81220232024: $138,430,06520242025: $141,355,0402025
Total assets$107,707,386Fiscal year 20252022: $72,423,07620222023: $89,385,84620232024: $101,949,39820242025: $107,707,3862025
Total liabilities$34,362,666Fiscal year 20252022: $19,399,61620222023: $31,361,73020232024: $37,175,25920242025: $34,362,6662025
Fiscal year ending August 2025
Revenue$149,672,688
Expenses$141,355,040
Net income$8,317,648
Net assets$73,344,720

Notable sources of revenue

Percent of total revenue
Contributions$56,059
Program services$148,843,402
Investment income$761,626
Other (net)$11,601

Assets / debt

Total assets$107,707,386
Total liabilities$34,362,666
Net assets$73,344,720

Compensation

Not in our extract for this year.

Fiscal year ending August 2024
Revenue$144,446,573
Expenses$138,430,065
Net income$6,016,508
Net assets$64,774,139

Notable sources of revenue

Percent of total revenue
Contributions$20,191
Program services$143,925,563
Investment income$488,299
Other (net)$12,520

Assets / debt

Total assets$101,949,398
Total liabilities$37,175,259
Net assets$64,774,139

Compensation

Not in our extract for this year.

Fiscal year ending August 2023
Revenue$118,297,630
Expenses$114,124,812
Net income$4,172,818
Net assets$58,024,116

Notable sources of revenue

Percent of total revenue
Contributions$68,394
Program services$117,957,746
Investment income$261,468
Other (net)$10,022

Assets / debt

Total assets$89,385,846
Total liabilities$31,361,730
Net assets$58,024,116

Compensation

Not in our extract for this year.

Fiscal year ending August 2022
Revenue$98,048,523
Expenses$93,545,312
Net income$4,503,211
Net assets$53,023,460

Notable sources of revenue

Percent of total revenue
Contributions$7,186
Program services$97,438,178
Investment income$359,805
Other (net)$243,354

Assets / debt

Total assets$72,423,076
Total liabilities$19,399,616
Net assets$53,023,460

Compensation

Officers and key employees$2,095,036
Share of expenses2.2%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?